Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 45 entries
Sorted by: Best Match Show Resources per page
Study of amniotic fluid in pregnant women infected with SARS-CoV-2 in first and second trimester. Is there evidence of vertical transmission?.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Rubio Lorente AM, Pola Guillén M, López Jimenez N, Moreno-Cid Garcia-Suelto M, Rodriguez Rodriguez E, Pascual Pedreño A.
PMID: 32862730
J Matern Fetal Neonatal Med. 2020 Aug 30;1-3. doi: 10.1080/14767058.2020.1811669. Epub 2020 Aug 30.

COVID-19 is a respiratory disease caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The effects of this infection on fetal development and whether there is vertical transmission are currently unknown. We present two cases of pregnant women with...

Cite
Rubio Lorente AM, Pola Guillén M, López Jimenez N, et al. Study of amniotic fluid in pregnant women infected with SARS-CoV-2 in first and second trimester. Is there evidence of vertical transmission?. J Matern Fetal Neonatal Med. 2020;1-3doi: 10.1080/14767058.2020.1811669.
Rubio Lorente, A. M., Pola Guillén, M., López Jimenez, N., Moreno-Cid Garcia-Suelto, M., Rodriguez Rodriguez, E., & Pascual Pedreño, A. (2020). Study of amniotic fluid in pregnant women infected with SARS-CoV-2 in first and second trimester. Is there evidence of vertical transmission?. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-3. https://doi.org/10.1080/14767058.2020.1811669
Rubio Lorente, Ana M, et al. "Study of amniotic fluid in pregnant women infected with SARS-CoV-2 in first and second trimester. Is there evidence of vertical transmission?." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2020): 1-3. doi: https://doi.org/10.1080/14767058.2020.1811669
Rubio Lorente AM, Pola Guillén M, López Jimenez N, Moreno-Cid Garcia-Suelto M, Rodriguez Rodriguez E, Pascual Pedreño A. Study of amniotic fluid in pregnant women infected with SARS-CoV-2 in first and second trimester. Is there evidence of vertical transmission?. J Matern Fetal Neonatal Med. 2020 Aug 30;1-3. doi: 10.1080/14767058.2020.1811669. Epub 2020 Aug 30. PMID: 32862730.
Copy Download .nbib Format: NLM
Localizing genesis in polydomain liquid crystal elastomers.

Soft matter

Fowler HE, Donovan BR, McCracken JM, López Jiménez F, White TJ.
PMID: 31701098
Soft Matter. 2020 Jan 02;16(2):330-336. doi: 10.1039/c9sm01923e.

Programming the local orientation of liquid crystal elastomers (LCEs) is a differentiated approach to prepare monolithic material compositions with localized deformation. Our prior efforts prepared LCEs with surface-enforced spatial variations in orientation to localize deformation when the LCEs were...

Cite
Fowler HE, Donovan BR, McCracken JM, et al. Localizing genesis in polydomain liquid crystal elastomers. Soft Matter. 2020;16(2):330-336doi: 10.1039/c9sm01923e.
Fowler, H. E., Donovan, B. R., McCracken, J. M., López Jiménez, F., & White, T. J. (2020). Localizing genesis in polydomain liquid crystal elastomers. Soft matter, 16(2), 330-336. https://doi.org/10.1039/c9sm01923e
Fowler, Hayden E, et al. "Localizing genesis in polydomain liquid crystal elastomers." Soft matter vol. 16,2 (2020): 330-336. doi: https://doi.org/10.1039/c9sm01923e
Fowler HE, Donovan BR, McCracken JM, López Jiménez F, White TJ. Localizing genesis in polydomain liquid crystal elastomers. Soft Matter. 2020 Jan 02;16(2):330-336. doi: 10.1039/c9sm01923e. PMID: 31701098.
Copy Download .nbib Format: NLM
[The importance of the number of antihypertensives in the progression of autosomal dominant polycystic kidney disease].

Nefrologia

Martínez Jiménez V, Hernández González AN, López Jiménez I, Rodríguez Peña L, Galbis Martínez L, Santa-Olalla González M, Ruiz Merino G, Guillén Navarro E.
PMID: 32950282
Nefrologia (Engl Ed). 2021 May-Jun;41(3):362-364. doi: 10.1016/j.nefro.2020.06.003. Epub 2020 Sep 17.

No abstract available.

Cite
Martínez Jiménez V, Hernández González AN, López Jiménez I, et al. La importancia del número de antihipertensivos en la progresión de la poliquistosis renal autosómica dominante. [The importance of the number of antihypertensives in the progression of autosomal dominant polycystic kidney disease]. Nefrologia (Engl Ed). 2020;41(3):362-364doi: 10.1016/j.nefro.2020.06.003.
Martínez Jiménez, V., Hernández González, A. N., López Jiménez, I., Rodríguez Peña, L., Galbis Martínez, L., Santa-Olalla González, M., Ruiz Merino, G., & Guillén Navarro, E. (2021). La importancia del número de antihipertensivos en la progresión de la poliquistosis renal autosómica dominante. [The importance of the number of antihypertensives in the progression of autosomal dominant polycystic kidney disease]. Nefrologia, 41(3), 362-364. https://doi.org/10.1016/j.nefro.2020.06.003
Martínez Jiménez, Víctor, et al. "La importancia del número de antihipertensivos en la progresión de la poliquistosis renal autosómica dominante." [The importance of the number of antihypertensives in the progression of autosomal dominant polycystic kidney disease]. Nefrologia vol. 41,3 (2021): 362-364. doi: https://doi.org/10.1016/j.nefro.2020.06.003
Martínez Jiménez V, Hernández González AN, López Jiménez I, Rodríguez Peña L, Galbis Martínez L, Santa-Olalla González M, Ruiz Merino G, Guillén Navarro E. La importancia del número de antihipertensivos en la progresión de la poliquistosis renal autosómica dominante. [The importance of the number of antihypertensives in the progression of autosomal dominant polycystic kidney disease]. Nefrologia (Engl Ed). 2021 May-Jun;41(3):362-364. doi: 10.1016/j.nefro.2020.06.003. Epub 2020 Sep 17. Spanish. PMID: 32950282.
Copy Download .nbib Format: NLM
Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country.

Experimental hematology & oncology

Muntañola A, Villacampa G, Hernández-Rivas JÁ, Alonso R, Mirás F, Osorio S, Baile M, Baltasar P, López Jiménez J, Hernandez-Rodriguez I, Valenciano S, Alfayate A, Gimeno E, Bárez A, Oliveira AC, Riaza R, Romero P, Delgado J, Yáñez L, Zabalza A, Torres A, Gómez-Roncero MI, Crespo M, Córdoba R, Mateos-Mazón JJ, Pérez S, Andreu R, Labrador J, Ruiz ME, Velasquez CA, Terol MJ, Santiago R, Vidal MJ, Campoy García F, Villalón L, Muiña BS, Soler JA, Seri C, Sánchez MJ, Cuesta A, Ramos R, Sánchez-Montalvá A, Ruiz-Camps I, González M, Abrisqueta P, Bosch F.
PMID: 33339537
Exp Hematol Oncol. 2020 Dec 18;9(1):37. doi: 10.1186/s40164-020-00195-x.

No abstract available.

Cite
Muntañola A, Villacampa G, Hernández-Rivas JÁ, et al. Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country. Exp Hematol Oncol. 2020;9(1):37doi: 10.1186/s40164-020-00195-x.
Muntañola, A., Villacampa, G., Hernández-Rivas, J. �. �., Alonso, R., Mirás, F., Osorio, S., Baile, M., Baltasar, P., López Jiménez, J., Hernandez-Rodriguez, I., Valenciano, S., Alfayate, A., Gimeno, E., Bárez, A., Oliveira, A. C., Riaza, R., Romero, P., Delgado, J., Yáñez, L., Zabalza, A., Torres, A., Gómez-Roncero, M. I., Crespo, M., Córdoba, R., Mateos-Mazón, J. J., Pérez, S., Andreu, R., Labrador, J., Ruiz, M. E., Velasquez, C. A., Terol, M. J., Santiago, R., Vidal, M. J., Campoy García, F., Villalón, L., Muiña, B. S., Soler, J. A., Seri, C., Sánchez, M. J., Cuesta, A., Ramos, R., Sánchez-Montalvá, A., Ruiz-Camps, I., González, M., Abrisqueta, P., Bosch, F. (2020). Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country. Experimental hematology & oncology, 9(1), 37. https://doi.org/10.1186/s40164-020-00195-x
Muntañola, Ana, et al. "Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country." Experimental hematology & oncology vol. 9,1 (2020): 37. doi: https://doi.org/10.1186/s40164-020-00195-x
Muntañola A, Villacampa G, Hernández-Rivas JÁ, Alonso R, Mirás F, Osorio S, Baile M, Baltasar P, López Jiménez J, Hernandez-Rodriguez I, Valenciano S, Alfayate A, Gimeno E, Bárez A, Oliveira AC, Riaza R, Romero P, Delgado J, Yáñez L, Zabalza A, Torres A, Gómez-Roncero MI, Crespo M, Córdoba R, Mateos-Mazón JJ, Pérez S, Andreu R, Labrador J, Ruiz ME, Velasquez CA, Terol MJ, Santiago R, Vidal MJ, Campoy García F, Villalón L, Muiña BS, Soler JA, Seri C, Sánchez MJ, Cuesta A, Ramos R, Sánchez-Montalvá A, Ruiz-Camps I, González M, Abrisqueta P, Bosch F. Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country. Exp Hematol Oncol. 2020 Dec 18;9(1):37. doi: 10.1186/s40164-020-00195-x. PMID: 33339537; PMCID: PMC7746919.
Copy Download .nbib Format: NLM
Risk of caesarean delivery in labour induction: a systematic review and external validation of predictive models.

BJOG : an international journal of obstetrics and gynaecology

López-Jiménez N, García-Sánchez F, Hernández-Pailos R, Rodrigo-Álvaro V, Pascual-Pedreño A, Moreno-Cid M, Delgado-Rodríguez M, Hernández-Martínez A.
PMID: 34559942
BJOG. 2021 Sep 24; doi: 10.1111/1471-0528.16947. Epub 2021 Sep 24.

BACKGROUND: Despite the existence of numerous published models predicting the risk of caesarean delivery in women undergoing induction of labour (IOL), validated models are scarce.OBJECTIVES: To systematically review and externally assess the predictive capacity of caesarean delivery risk models...

Cite
López-Jiménez N, García-Sánchez F, Hernández-Pailos R, et al. Risk of caesarean delivery in labour induction: a systematic review and external validation of predictive models. BJOG. 2021;doi: 10.1111/1471-0528.16947.
López-Jiménez, N., García-Sánchez, F., Hernández-Pailos, R., Rodrigo-Álvaro, V., Pascual-Pedreño, A., Moreno-Cid, M., Delgado-Rodríguez, M., & Hernández-Martínez, A. (2021). Risk of caesarean delivery in labour induction: a systematic review and external validation of predictive models. BJOG : an international journal of obstetrics and gynaecology, . https://doi.org/10.1111/1471-0528.16947
López-Jiménez, N, et al. "Risk of caesarean delivery in labour induction: a systematic review and external validation of predictive models." BJOG : an international journal of obstetrics and gynaecology vol. (2021). doi: https://doi.org/10.1111/1471-0528.16947
López-Jiménez N, García-Sánchez F, Hernández-Pailos R, Rodrigo-Álvaro V, Pascual-Pedreño A, Moreno-Cid M, Delgado-Rodríguez M, Hernández-Martínez A. Risk of caesarean delivery in labour induction: a systematic review and external validation of predictive models. BJOG. 2021 Sep 24; doi: 10.1111/1471-0528.16947. Epub 2021 Sep 24. PMID: 34559942.
Copy Download .nbib Format: NLM
Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib.

British journal of haematology

Solano de la Asunción C, Terol MJ, Saus A, Olea B, Giménez E, Albert E, López-Jiménez J, Andreu R, García D, Fox L, Remigia MJ, Amat P, Solano C, Navarro D.
PMID: 34402042
Br J Haematol. 2021 Nov;195(4):637-641. doi: 10.1111/bjh.17732. Epub 2021 Aug 16.

No abstract available.

Cite
Solano de la Asunción C, Terol MJ, Saus A, et al. Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib. Br J Haematol. 2021;195(4):637-641doi: 10.1111/bjh.17732.
Solano de la Asunción, C., Terol, M. J., Saus, A., Olea, B., Giménez, E., Albert, E., López-Jiménez, J., Andreu, R., García, D., Fox, L., Remigia, M. J., Amat, P., Solano, C., & Navarro, D. (2021). Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib. British journal of haematology, 195(4), 637-641. https://doi.org/10.1111/bjh.17732
Solano de la Asunción, Carlos, et al. "Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib." British journal of haematology vol. 195,4 (2021): 637-641. doi: https://doi.org/10.1111/bjh.17732
Solano de la Asunción C, Terol MJ, Saus A, Olea B, Giménez E, Albert E, López-Jiménez J, Andreu R, García D, Fox L, Remigia MJ, Amat P, Solano C, Navarro D. Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib. Br J Haematol. 2021 Nov;195(4):637-641. doi: 10.1111/bjh.17732. Epub 2021 Aug 16. PMID: 34402042.
Copy Download .nbib Format: NLM
Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism.

TH open : companion journal to thrombosis and haemostasis

Iñurrieta A, Pedrajas JM, Núñez MJ, López-Jiménez L, Velo-García A, García JC, Lecumberri R, Jiménez D, Pons I, Monreal M.
PMID: 31249971
TH Open. 2018 Dec 10;2(4):e428-e436. doi: 10.1055/s-0038-1676359. eCollection 2018 Oct.

No abstract available.

Cite
Iñurrieta A, Pedrajas JM, Núñez MJ, et al. Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism. TH Open. 2018;2(4):e428-e436doi: 10.1055/s-0038-1676359.
Iñurrieta, A., Pedrajas, J. M., Núñez, M. J., López-Jiménez, L., Velo-García, A., García, J. C., Lecumberri, R., Jiménez, D., Pons, I., Monreal, M. (2018). Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism. TH open : companion journal to thrombosis and haemostasis, 2(4), e428-e436. https://doi.org/10.1055/s-0038-1676359
Iñurrieta, Amaia, et al. "Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism." TH open : companion journal to thrombosis and haemostasis vol. 2,4 (2018): e428-e436. doi: https://doi.org/10.1055/s-0038-1676359
Iñurrieta A, Pedrajas JM, Núñez MJ, López-Jiménez L, Velo-García A, García JC, Lecumberri R, Jiménez D, Pons I, Monreal M. Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism. TH Open. 2018 Dec 10;2(4):e428-e436. doi: 10.1055/s-0038-1676359. eCollection 2018 Oct. PMID: 31249971; PMCID: PMC6524920.
Copy Download .nbib Format: NLM
Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden.

Oncotarget

Frampton AE, Prado MM, López-Jiménez E, Fajardo-Puerta AB, Jawad ZAR, Lawton P, Giovannetti E, Habib NA, Castellano L, Stebbing J, Krell J, Jiao LR.
PMID: 29721179
Oncotarget. 2018 Apr 10;9(27):19006-19013. doi: 10.18632/oncotarget.24873. eCollection 2018 Apr 10.

BACKGROUND: Glypican-1 (GPC1) is expressed in pancreatic ductal adenocarcinoma (PDAC) cells and adjacent stromal fibroblasts. Recently, GPC1 circulating exosomes (crExos) have been shown to be able to detect early stages of PDAC. In this study, we investigated the usefulness...

Cite
Frampton AE, Prado MM, López-Jiménez E, et al. Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden. Oncotarget. 2018;9(27):19006-19013doi: 10.18632/oncotarget.24873.
Frampton, A. E., Prado, M. M., López-Jiménez, E., Fajardo-Puerta, A. B., Jawad, Z. A. R., Lawton, P., Giovannetti, E., Habib, N. A., Castellano, L., Stebbing, J., Krell, J., & Jiao, L. R. (2018). Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden. Oncotarget, 9(27), 19006-19013. https://doi.org/10.18632/oncotarget.24873
Frampton, Adam E, et al. "Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden." Oncotarget vol. 9,27 (2018): 19006-19013. doi: https://doi.org/10.18632/oncotarget.24873
Frampton AE, Prado MM, López-Jiménez E, Fajardo-Puerta AB, Jawad ZAR, Lawton P, Giovannetti E, Habib NA, Castellano L, Stebbing J, Krell J, Jiao LR. Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden. Oncotarget. 2018 Apr 10;9(27):19006-19013. doi: 10.18632/oncotarget.24873. eCollection 2018 Apr 10. PMID: 29721179; PMCID: PMC5922373.
Copy Download .nbib Format: NLM
[Conceptual proposal for an operational model of integrated care in public health services for children].

Boletin medico del Hospital Infantil de Mexico

Pérez Cuevas R, Nakamura López MÁ, Pascasio Martínez ZL, Mancilla Gallegos NV, Montesinos Álvarez ME, Rodríguez Ramos SL, Gómez Pérez JA, Pérez López MLÁ, López Jiménez ME.
PMID: 29421637
Bol Med Hosp Infant Mex. 2014 Nov - Dec;71(6):396-400. doi: 10.1016/j.bmhimx.2015.01.006. Epub 2015 May 19.

No abstract available.

Cite
Pérez Cuevas R, Nakamura López MÁ, Pascasio Martínez ZL, et al. Propuesta conceptual de un modelo operativo de atención integrada de servicios de salud pública para la niñez. [Conceptual proposal for an operational model of integrated care in public health services for children]. Bol Med Hosp Infant Mex. 2015;71(6):396-400doi: 10.1016/j.bmhimx.2015.01.006.
Pérez Cuevas, R., Nakamura López, M. �. �., Pascasio Martínez, Z. L., Mancilla Gallegos, N. V., Montesinos Álvarez, M. E., Rodríguez Ramos, S. L., Gómez Pérez, J. A., Pérez López, M. L. �. �., & López Jiménez, M. E. (2014). Propuesta conceptual de un modelo operativo de atención integrada de servicios de salud pública para la niñez. [Conceptual proposal for an operational model of integrated care in public health services for children]. Boletin medico del Hospital Infantil de Mexico, 71(6), 396-400. https://doi.org/10.1016/j.bmhimx.2015.01.006
Pérez Cuevas, Ricardo, et al. "Propuesta conceptual de un modelo operativo de atención integrada de servicios de salud pública para la niñez." [Conceptual proposal for an operational model of integrated care in public health services for children]. Boletin medico del Hospital Infantil de Mexico vol. 71,6 (2014): 396-400. doi: https://doi.org/10.1016/j.bmhimx.2015.01.006
Pérez Cuevas R, Nakamura López MÁ, Pascasio Martínez ZL, Mancilla Gallegos NV, Montesinos Álvarez ME, Rodríguez Ramos SL, Gómez Pérez JA, Pérez López MLÁ, López Jiménez ME. Propuesta conceptual de un modelo operativo de atención integrada de servicios de salud pública para la niñez. [Conceptual proposal for an operational model of integrated care in public health services for children]. Bol Med Hosp Infant Mex. 2014 Nov - Dec;71(6):396-400. doi: 10.1016/j.bmhimx.2015.01.006. Epub 2015 May 19. Spanish. PMID: 29421637.
Copy Download .nbib Format: NLM
Checklist of the helminth parasites of the genus Profundulus Hubbs, 1924 (Cyprinodontiformes, Profundulidae), an endemic family of freshwater fishes in Middle-America.

ZooKeys

Pinacho-Pinacho CD, García-Varela M, Hernández-Orts JS, Mendoza-Palmero CA, Sereno-Uribe AL, Martínez-Ramírez E, Andrade-Gómez L, López-Jiménez A, Hernández-Cruz E, Pérez-Ponce de León G.
PMID: 26478697
Zookeys. 2015 Sep 28;(523):1-30. doi: 10.3897/zookeys.523.6088. eCollection 2015.

From December 2012 to November 2014, 267 fish belonging to the family Profundulidae (representing nine of the 11 species of the genus Profundulus) were collected in 26 localities of Middle-America, across southern Mexico, Guatemala, and Honduras, comprising the distribution...

Cite
Pinacho-Pinacho CD, García-Varela M, Hernández-Orts JS, et al. Checklist of the helminth parasites of the genus Profundulus Hubbs, 1924 (Cyprinodontiformes, Profundulidae), an endemic family of freshwater fishes in Middle-America. Zookeys. 2015;(523):1-30doi: 10.3897/zookeys.523.6088.
Pinacho-Pinacho, C. D., García-Varela, M., Hernández-Orts, J. S., Mendoza-Palmero, C. A., Sereno-Uribe, A. L., Martínez-Ramírez, E., Andrade-Gómez, L., López-Jiménez, A., Hernández-Cruz, E., & Pérez-Ponce de León, G. (2015). Checklist of the helminth parasites of the genus Profundulus Hubbs, 1924 (Cyprinodontiformes, Profundulidae), an endemic family of freshwater fishes in Middle-America. ZooKeys, (523), 1-30. https://doi.org/10.3897/zookeys.523.6088
Pinacho-Pinacho, Carlos Daniel, et al. "Checklist of the helminth parasites of the genus Profundulus Hubbs, 1924 (Cyprinodontiformes, Profundulidae), an endemic family of freshwater fishes in Middle-America." ZooKeys vol. ,523 (2015): 1-30. doi: https://doi.org/10.3897/zookeys.523.6088
Pinacho-Pinacho CD, García-Varela M, Hernández-Orts JS, Mendoza-Palmero CA, Sereno-Uribe AL, Martínez-Ramírez E, Andrade-Gómez L, López-Jiménez A, Hernández-Cruz E, Pérez-Ponce de León G. Checklist of the helminth parasites of the genus Profundulus Hubbs, 1924 (Cyprinodontiformes, Profundulidae), an endemic family of freshwater fishes in Middle-America. Zookeys. 2015 Sep 28;(523):1-30. doi: 10.3897/zookeys.523.6088. eCollection 2015. PMID: 26478697; PMCID: PMC4602295.
Copy Download .nbib Format: NLM
Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).

PloS one

González-Rincón J, Garcia-Vela JA, Gómez S, Fernández-Cuevas B, Nova-Gurumeta S, Pérez-Sanz N, Alcoceba M, González M, Anguita E, López-Jiménez J, González-Barca E, Yáñez L, Pérez-Persona E, de la Serna J, Fernández-Zarzoso M, Deben G, Peñalver FJ, Fernández MC, de Oteyza JP, Andreu MÁ, Ruíz-Guinaldo MÁ, Paz-Arias R, García-Malo MD, Recasens V, Collado R, Córdoba R, Navarro-Matilla B, Sánchez-Beato M, García-Marco JA.
PMID: 34506616
PLoS One. 2021 Sep 10;16(9):e0257353. doi: 10.1371/journal.pone.0257353. eCollection 2021.

Chronic Lymphocytic Leukemia (CLL) is the most prevalent leukemia in Western countries and is notable for its variable clinical course. This variability is partly reflected by the mutational status of IGHV genes. Many CLL samples have been studied in...

Cite
González-Rincón J, Garcia-Vela JA, Gómez S, et al. Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM). PLoS One. 2021;16(9):e0257353doi: 10.1371/journal.pone.0257353.
González-Rincón, J., Garcia-Vela, J. A., Gómez, S., Fernández-Cuevas, B., Nova-Gurumeta, S., Pérez-Sanz, N., Alcoceba, M., González, M., Anguita, E., López-Jiménez, J., González-Barca, E., Yáñez, L., Pérez-Persona, E., de la Serna, J., Fernández-Zarzoso, M., Deben, G., Peñalver, F. J., Fernández, M. C., de Oteyza, J. P., Andreu, M. �. �., Ruíz-Guinaldo, M. �. �., Paz-Arias, R., García-Malo, M. D., Recasens, V., Collado, R., Córdoba, R., Navarro-Matilla, B., Sánchez-Beato, M., & García-Marco, J. A. (2021). Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM). PloS one, 16(9), e0257353. https://doi.org/10.1371/journal.pone.0257353
González-Rincón, Julia, et al. "Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)." PloS one vol. 16,9 (2021): e0257353. doi: https://doi.org/10.1371/journal.pone.0257353
González-Rincón J, Garcia-Vela JA, Gómez S, Fernández-Cuevas B, Nova-Gurumeta S, Pérez-Sanz N, Alcoceba M, González M, Anguita E, López-Jiménez J, González-Barca E, Yáñez L, Pérez-Persona E, de la Serna J, Fernández-Zarzoso M, Deben G, Peñalver FJ, Fernández MC, de Oteyza JP, Andreu MÁ, Ruíz-Guinaldo MÁ, Paz-Arias R, García-Malo MD, Recasens V, Collado R, Córdoba R, Navarro-Matilla B, Sánchez-Beato M, García-Marco JA. Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM). PLoS One. 2021 Sep 10;16(9):e0257353. doi: 10.1371/journal.pone.0257353. eCollection 2021. PMID: 34506616; PMCID: PMC8432772.
Copy Download .nbib Format: NLM
Exploratory field study on the effects of porcine circovirus 2 (PCV-2) sow vaccination at different physiological stages mimicking blanket vaccination.

Porcine health management

Pleguezuelos P, Sibila M, Cuadrado R, López-Jiménez R, Pérez D, Huerta E, Llorens AM, Núñez JI, Segalés J, López-Soria S.
PMID: 33902747
Porcine Health Manag. 2021 Apr 26;7(1):35. doi: 10.1186/s40813-021-00213-2.

BACKGROUND: The objective of the present study was to explore the benefits of Porcine circovirus 2 (PCV-2) blanket vaccination in a sow herd on productive parameters, PCV-2 infection and immune status in sows and their progeny. For this purpose,...

Cite
Pleguezuelos P, Sibila M, Cuadrado R, et al. Exploratory field study on the effects of porcine circovirus 2 (PCV-2) sow vaccination at different physiological stages mimicking blanket vaccination. Porcine Health Manag. 2021;7(1):35doi: 10.1186/s40813-021-00213-2.
Pleguezuelos, P., Sibila, M., Cuadrado, R., López-Jiménez, R., Pérez, D., Huerta, E., Llorens, A. M., Núñez, J. I., Segalés, J., & López-Soria, S. (2021). Exploratory field study on the effects of porcine circovirus 2 (PCV-2) sow vaccination at different physiological stages mimicking blanket vaccination. Porcine health management, 7(1), 35. https://doi.org/10.1186/s40813-021-00213-2
Pleguezuelos, Patricia, et al. "Exploratory field study on the effects of porcine circovirus 2 (PCV-2) sow vaccination at different physiological stages mimicking blanket vaccination." Porcine health management vol. 7,1 (2021): 35. doi: https://doi.org/10.1186/s40813-021-00213-2
Pleguezuelos P, Sibila M, Cuadrado R, López-Jiménez R, Pérez D, Huerta E, Llorens AM, Núñez JI, Segalés J, López-Soria S. Exploratory field study on the effects of porcine circovirus 2 (PCV-2) sow vaccination at different physiological stages mimicking blanket vaccination. Porcine Health Manag. 2021 Apr 26;7(1):35. doi: 10.1186/s40813-021-00213-2. PMID: 33902747; PMCID: PMC8077688.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 45 entries